The HSP70 gene silencing in breast cancer cells was also shown to impair the small extracellular vesicle-mediated intercellular delivery of HSP70 that conferred energy metabolism reprogramming and resistance to adriamycin in the tumor cell-recipients [154]. The gene discussed is HSPA1A; the disease is breast carcinoma.